The groundbreaking success of Viagra undeniably reshaped the drug landscape, but betting in companies primarily reliant on off-patent versions presents a challenging picture. Despite early earnings were impressive, the cessation of patents and the appearance of cheaper alternatives have weakened sales. Thus, a thorough evaluation of present income